Clinical data | |
---|---|
Trade names | Dricol, Fentrinol, Nalde |
Other names | Amidefrine; MJ-1996; MJ-5190; 3-Methylsulfonamidyl-β-hydroxy-N-methylphenethylamine; 3-Methylsulfonamidyl-β-hydroxy-N-methyl-β-phenylethylamine |
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C10H16N2O3S |
Molar mass | 244.31 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Amidephrine (BAN ), or amidefrine, sold under the brand name Fentrinol among others, is a selective α1-adrenergic receptor agonist which is described as an adrenergic or sympathomimetic, vasoconstrictor, and topical nasal decongestant used to treat allergic rhinitis.[1][2][3][4][5] It is used as the mesylate salt, which has the generic names amidefrine mesilate (INN ) and amidephrine mesylate (USAN ).[2] The drug is a substituted phenethylamine derivative and is also known as 3-methylsulfonamidyl-β-hydroxy-N-methylphenethylamine.[2][1][6] As of 2000, it remained marketed only in Austria.[3]